Biofrontera Inc.
BFRIW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001858685
No open-market purchases or sales by Biofrontera Inc. insiders were filed in the last 90 days; 5 institutions reported holding it in 13F filings for Q2 2026, worth $4.48K in total; no superinvestor holds it.
Other share classesBFRI
Q4 2021 vs. Q3 2021
How the institutions holding Biofrontera Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 0 | 5 | +5 |
| Shares | 0 | 307.6K | +307.6K |
| Value | $0 | $1.11M | +$1.11M |
New holders (5)
Institutions that held Biofrontera Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Bard Associates Inc | 210,100 | $756.0K | 0.25% |
| Empery Asset Management, LP | 75,000 | $270.0K | 0.56% |
| Warberg Asset Management LLC | 18,487 | $67.0K | 0.02% |
| UBS Group AG | 2,750 | $10.0K | 0.00% |
| Federation des caisses Desjardins du Quebec | 1,250 | $4.50K | 0.00% |
Sold out (0)
Institutions that held Biofrontera Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
None.